Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors (Q43570514)

24 November 2017

Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

3 January 2023

0 references

N. S. Buckholtz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3374263

3 January 2023

D. F. Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3374263

3 January 2023

D. X. Freedman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3374263

3 January 2023

language of work or name

English

0 references

publication date

1 January 1988

1 reference

full work available at URL

24 November 2017

https://api.elsevier.com/content/article/PII:0024320588903426?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

https://api.elsevier.com/content/article/PII:0024320588903426?httpAccept=text/plain

3 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

3 January 2023

1 reference

24 November 2017

42

1 reference

24 November 2017

24

1 reference

24 November 2017

2439-2445

1 reference

Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain.

24 November 2017

1

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding

3 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour.

3 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonists

3 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites

3 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites.

3 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Regional serotonin receptor studies: chronic methysergide treatment induces a selective and dose-dependent decrease in serotonin-2 receptors in mouse cerebral cortex.

3 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.

3 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

3 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists

3 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).

3 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists.

3 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity.

3 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).

3 January 2023

19

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues.

3 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

3 January 2023

21

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Protein measurement with the Folin phenol reagent

3 January 2023

24

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

[3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.

3 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Binding to the serotonin 5-HT2 receptor by the enantiomers of 125I-DOI.

3 January 2023

27

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain

3 January 2023

28

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Autoradiographic localization of binding sites for 125I-DOI, a new psychotomimetic radioligand, in the rat brain

3 January 2023

29

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane

3 January 2023

32

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Mechanistic studies on DOM as a discriminative stimulus

3 January 2023

33

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

3 January 2023

35

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs.

3 January 2023

38

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex.

3 January 2023

39

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site.

3 January 2023

41

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Serotonergic agonists stimulate inositol lipid metabolism in rabbit platelets

3 January 2023

43

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine

3 January 2023

44

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

3 HLysergic Acid Diethylamide: Cellular Autoradiographic Localization in Rat Brain

3 January 2023

45

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Is waning of a 5-hydroxytryptamine (5-HT)-mediated syndrome due to 5-HT2 receptor down-regulation?

3 January 2023

46

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

Effects of antidepressant drug combinations on cortical 5-HT2 receptors and wet-dog shakes in rats.

3 January 2023

47

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90342-6

3 January 2023

Identifiers

1 reference

24 November 2017

1 reference